drugset / Trial / NCT00761137
Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
Phase 2
Completed
19 enrolled
NeuroHealing Pharmaceuticals Inc.
Michael J. Fox Foundation for Parkinson's Research · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The primary goal of the study is to evaluate the safety and potential efficacy of intra-oral dissolvable NH004 films to improve the short-term symptoms of sialorrhea (drooling) in Parkinson's disease (PD) patients.
Timeline
- Start
- 2008-03
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tropicamide | Small molecule | 0.3 mg | Other |
| Subject | tropicamide | Small molecule | 1 mg | Other |
| Subject | tropicamide | Small molecule | 3 mg | Other |